GBT Technologies Inc (GTCH)

[bucks2pennies]

More to ponder. Does it appear to you as it does to me that GTCH engineered the sale of GTCH/Tokenize strictly on functional basis having the sale of the 6 primary AI patent components sold (contracted for at least) BEFORE stating that both GTCH and Tokenize would be sold in their entirety? The management and their partners deciding that their best options would be to do so - AI freestanding (viable products to generate revenue left to those individual companies) and the Chip side (Manufacturing products to generate revenue will be left to the individual company purchasing the combined entity of GTCH and Tokenize to include the purchase (ownership) of all remaining patents)?

This arrangement is becoming more clear to me (forming my own opinion) as a VERY clean way of making the potential of their patents achieve desired goals.

In effect their patents will be distributed between three fully operational companies yet necessitating the 'sharing' of the central component: AI and its interlocking association among all three companies yet allowing FULL freedom by those companies to utilize the FULL capabilities of the AI to generate their own productive needs. The AI component, IMO, cannot be distinguished completely within each company - they must SHARE some of the mutual uses the AI performs.

So.... what I am suggesting is that SHs can expect that the company to purchase the combined rights of both GTCH and the Tokenize partners WILL be a CHIP manufacturing entity...along with the 'medical device' (using chip technology) to measure human heath monitoring capabilities.

While the above is strictly my opinion, I offer it as 'food for thought' in trying to get a handle on GTCH SH expectations.